Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of “Moderate Buy” by Analysts
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy […]
15 Apr 10:32 · The Markets Daily